GlassScriptPhysician profile
Amy L Hendrix
NPI 1336317346
$3,452.82
in general payments reported to CMS, 2019-2025
17 companies · $758 in 2025
The $758 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $292 · 2022: $522 · 2023: $525 · 2024: $1,356 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,549 · Education: $90.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,549.02 |
| Education | $90.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,503.72 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $691.82 | 2022-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $274.93 | 2024 | Sotyktu |
| Ucb, INC. | $223.62 | 2021-2025 | Bimzelx |
| Lilly USA, LLC | $141.76 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Kyowa Kirin, INC. | $140.00 | 2023 | Poteligeo |
| Sun Pharmaceutical Industries INC. | $80.79 | 2021-2023 | Ilumya |
| Novartis Pharmaceuticals Corporation | $78.36 | 2021-2024 | |
| Leo Pharma INC. | $67.02 | 2022-2025 | Adbry |
| Amgen INC. | $65.27 | 2024-2025 | Otezla, Otezla |
| Allergan, INC. | $48.00 | 2022 | |
| Revance Therapeutics, INC. | $34.22 | 2024 | Daxxify |
| Janssen Biotech, INC. | $30.39 | 2023 | Tremfya |
| Strata Skin Sciences, INC. | $24.58 | 2025 | Xtrac |
| Biofrontera INC. | $18.25 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $16.62 | 2024 | |
| Incyte Corporation | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.